The enhanced expression of ERR-β2 can be induced by the ERR-β agonist, and the inhibition of splicing-regulatory cdc2-like kinase leads to the suppression of the growth and migration of GBM cells and intracranial tumors [10]. The gene discussed is ESRRB; the disease is glioblastoma.